Overview
Sofia Merajver is an Oncologist in Ann Arbor, Michigan. Dr. Merajver is highly rated in 13 conditions, according to our data. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, and Angiosarcoma. Dr. Merajver is currently accepting new patients.
Her clinical research consists of co-authoring 151 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Blue Cross Blue Shield
- McLaren Health
- Humana
Locations
1500 E Medical Ctr Dr, Ann Arbor, MI 48109
1500 E Medical Ctr, Suite 0331, Ann Arbor, MI 48109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Regents Of The University Of Michigan
Rashmi Chugh is an Oncologist and a Hematologist in Ann Arbor, Michigan. Dr. Chugh is highly rated in 30 conditions, according to our data. Her top areas of expertise are Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Ewing Sarcoma, and Desmoid Tumor.
Regents Of The University Of Michigan
Scott Schuetze is an Oncologist in Ann Arbor, Michigan. Dr. Schuetze is highly rated in 28 conditions, according to our data. His top areas of expertise are Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Undifferentiated Pleomorphic Sarcoma.
Regents Of The University Of Michigan
Francis Worden is an Oncologist and a Pediatrics provider in Ann Arbor, Michigan. Dr. Worden is highly rated in 31 conditions, according to our data. His top areas of expertise are Laryngeal Cancer, Thyroid Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Throat Cancer.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Angiosarcoma
- Advanced
- BRCA Positive Breast Cancer
- Breast Cancer in Men
- HER2 Negative Breast Cancer
- Metastatic Brain Tumor
- Ovarian Cancer
- Ovarian Carcinosarcoma
- Experienced
- Anal Cancer
- Bladder Cancer
- Brain Tumor
- Desmoplastic Small Round Cell Tumor
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Lung Cancer